Repository logo
 
Publication

What should we advise MAFLD patients to eat and drink?

dc.contributor.authorMachado, Mariana Verdelho
dc.date.accessioned2023-12-14T21:40:47Z
dc.date.available2023-12-14T21:40:47Z
dc.date.issued2021-10
dc.description.abstractIn a time of food abundance and waste, and when sedentarism is the norm, metabolic-associated fatty liver disease (MAFLD) has become a major health threat in the Western world. While research is committed to finding a pharmacological treatment for MAFLD, it is time to go back to the basis and address the behavioral pathogenesis of MAFLD. All patients with MAFLD, irrespective of body weight, should be submitted to thorough dietary counseling. Diet is a learned behavior and should be addressed holistically and in a personalized fashion. The benefits of a suitable diet surpass an improvement of liver disease, having the potential to improve cardiovascularand cancer-related mortality, in patients with MAFLD. This review summarizes the current state of the art of diet on MAFLD, presenting straightforward recommendations for everyday practice.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.doi10.20517/mtod.2021.11pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.26/48493
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.subjectMAFLDpt_PT
dc.subjectDietpt_PT
dc.subjectRecommendationspt_PT
dc.titleWhat should we advise MAFLD patients to eat and drink?pt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.titleMetabolism and Target Organ Damagept_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
4369.pdf
Size:
496.58 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.85 KB
Format:
Item-specific license agreed upon to submission
Description: